Xuelu Wang

Xuelu Wang is an Associate Principal Scientist specializing in novel drug modalities and protein engineering at AstraZeneca, a position they have held since 2021. They previously served as a Senior Scientist and have accumulated extensive research experience as a Postdoctoral Research Associate at the University of Cambridge and as a Novo Nordisk Postdoctoral Research Fellow at the University of Oxford. Xuelu earned a Bachelor's degree in Life Science from the University of Science and Technology of China and completed a PhD in Biochemistry at the University of Cambridge.